Genetic and Clinical Characteristics of Neurofibromatosis Type 1 in Japan
Author Information
Author(s): Futagawa Mashu, Okazaki Tetsuya, Nakata Eiji, Fukano Chika, Osumi Risa, Kato Fumino, Urakawa Yusaku, Yamamoto Hideki, Ozaki Toshifumi, Hirasawa Akira
Primary Institution: Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Hypothesis
This study aimed to elucidate the detailed genetic and clinical characteristics of NF1 in a hereditary tumor cohort.
Conclusion
The study found that 92.3% of suspected patients with NF1 had detectable genetic changes linked to NF1, highlighting the importance of genetic testing in managing the condition.
Supporting Evidence
- 81.8% of patients had germline pathogenic variants.
- 40.0% of adult patients presented with malignancies.
- Hypertension was observed in 30.6% of adult patients.
Takeaway
Neurofibromatosis type 1 is a genetic disorder that can cause skin changes and tumors, and this study shows that many patients have genetic changes that can help doctors take better care of them.
Methodology
The study involved genetic testing and clinical data analysis of 44 patients with suspected NF1, using sequencing and copy number assays.
Limitations
The study is limited by its relatively small sample size and the cross-sectional nature of data collection.
Participant Demographics
The cohort included 44 patients, with a slight predominance of females and a wide age range at the first visit.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website